全文获取类型
收费全文 | 41597篇 |
免费 | 4056篇 |
国内免费 | 2416篇 |
专业分类
耳鼻咽喉 | 311篇 |
儿科学 | 1268篇 |
妇产科学 | 356篇 |
基础医学 | 6673篇 |
口腔科学 | 1444篇 |
临床医学 | 5420篇 |
内科学 | 5687篇 |
皮肤病学 | 441篇 |
神经病学 | 3088篇 |
特种医学 | 1309篇 |
外国民族医学 | 8篇 |
外科学 | 6825篇 |
综合类 | 7113篇 |
现状与发展 | 15篇 |
一般理论 | 2篇 |
预防医学 | 704篇 |
眼科学 | 839篇 |
药学 | 2136篇 |
23篇 | |
中国医学 | 1055篇 |
肿瘤学 | 3352篇 |
出版年
2024年 | 24篇 |
2023年 | 601篇 |
2022年 | 793篇 |
2021年 | 1371篇 |
2020年 | 1621篇 |
2019年 | 1416篇 |
2018年 | 1514篇 |
2017年 | 1649篇 |
2016年 | 1803篇 |
2015年 | 2048篇 |
2014年 | 3650篇 |
2013年 | 4264篇 |
2012年 | 2959篇 |
2011年 | 3501篇 |
2010年 | 2877篇 |
2009年 | 2570篇 |
2008年 | 2438篇 |
2007年 | 2449篇 |
2006年 | 2150篇 |
2005年 | 1864篇 |
2004年 | 1461篇 |
2003年 | 1110篇 |
2002年 | 766篇 |
2001年 | 586篇 |
2000年 | 438篇 |
1999年 | 270篇 |
1998年 | 233篇 |
1997年 | 197篇 |
1996年 | 139篇 |
1995年 | 138篇 |
1994年 | 136篇 |
1993年 | 100篇 |
1992年 | 84篇 |
1991年 | 71篇 |
1990年 | 74篇 |
1989年 | 62篇 |
1988年 | 63篇 |
1987年 | 47篇 |
1986年 | 49篇 |
1985年 | 64篇 |
1984年 | 47篇 |
1983年 | 37篇 |
1982年 | 62篇 |
1981年 | 57篇 |
1980年 | 70篇 |
1979年 | 38篇 |
1978年 | 26篇 |
1977年 | 30篇 |
1976年 | 27篇 |
1975年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Dental materials》2022,38(8):1283-1300
ObjectivesTo compare new bone formation in mandibular critical-sized bone defects (CSBDs) in healthy, diabetic, osteoporotic, and diabetic-osteoporotic rats filled with bioceramics (BCs) with or without bone marrow mesenchymal stem cells (BMSCs).MethodsA total of 64 adult female Sprague-Dawley rats were randomized into four groups (n = 16 per group): Group 1 healthy, Group 2 diabetic, Group 3 osteoporotic, and Group 4 diabetic-osteoporotic rats. Streptozotocin was used to induce type 1 diabetes in Group 2 and 4, while bilateral ovariectomy was used to induce osteoporosis in Group 3 and 4. The central portion of the rat mandibular symphysis was used as a physiological CSBD. In each group, eight defects were filled with BC (hydroxypatatite 60% and β-tricalcium phosphate 40%) alone and eight with BMSCs cultured on BC. The animals were sacrificed at 4 and 8 weeks, and the mandibles were processed for micro-computed tomography to analyze radiological union and bone mineral density (BMD); histological analysis of the bone union; and immunohistochemical analysis, which included immunoreactivity of vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2).ResultsIn all groups (healthy, diabetics, osteoporotics, and diabetics-osteoporotics), the CSBDs filled with BC + BMSCs showed greater radiological bone union, BMD, histological bone union, and more VEGF and BMP-2 positivity, in comparison with CSBDs treated with BC alone (at 4 and 8 weeks).ConclusionsApplication of BMSCs cultured on BCs improves bone regeneration in CSBDs compared with application of BCs alone in healthy, diabetic, osteoporotic, and diabetic-osteoporotic rats. 相似文献
4.
5.
Effect of Replacement of Wharton Acellular Jelly With FBS on the Expression of Megakaryocyte Linear Markers in Hematopoietic Stem Cells CD34+ 下载免费PDF全文
zahra Jalili Behnam Emamgolizadeh Hossein Abbaszadeh Shahla JaliliMehdi Derakhshani Mehdi YousefiMehdi TalebiKarim Shams Asenjan Ali Akabr Movassaghpour 《Asian Pacific journal of cancer prevention》2022,23(10):3281-3286
Objective: Animal environments for the growth of stem cells cause the transmission of some diseases and immune problems for the recipient. Accordingly, replacing these environments with healthy environments, at least with human resources, is essential. One of the media that can be used as an alternative to animal serums is Wharton acellular jelly (AWJ). Therefore, in this study, we intend to replace FBS with Wharton jelly and investigate its effect on the expression of megakaryocyte-related genes and markers in stem cells. Materials and Methods: In this study, cord blood-derived CD34 positive HSCs were cultured and expanded in the presence of cytokines including SCF, TPO, and FLT3-L. Then, the culture of expanded CD34 positive HSCs was performed in two groups: 1) IMDM culture medium containing 10% FBS and 100 ng / ml thrombopoietin cytokine 2) IMDM culture medium containing 10% AWJ, 100 ng / ml thrombopoietin cytokine. Finally, CD41 expressing cells were analyzed with the flow cytometry method. The genes related to megakaryocyte lineage including FLI1 and GATA2 were also evaluated using the RT-PCR technique. Results: The expression of CD41, a specific marker of megakaryocyte lineage in culture medium containing Wharton acellular jelly was increased compared to the FBS group. Additionally, the expression of GATA2 and FLI1 genes was significantly increased related to the control group. Conclusion: This study provided evidence of differentiation of CD34 positive hematopoietic stem cells from umbilical cord blood to megakaryocytes in a culture medium containing AWJ. 相似文献
6.
《Hematology/oncology and stem cell therapy》2021,14(4):275-289
Breast cancer has the highest incidence rate of malignancy in women worldwide. A major clinical challenge faced by patients with breast cancer treated by conventional therapies is frequent relapse. This relapse has been attributed to the cancer stem cell (CSC) population that resides within the tumor and possess stemness properties. Breast CSCs are generated when breast cancer cells undergo epithelial-mesenchymal transition resulting in aggressive, highly metastatic, and invasive phenotypes that exhibit resistance towards chemotherapeutics. Metastasis, a phenomenon that aids in the migration of breast CSCs, occurs through any of three different routes: hematogenous, lymphatic, and transcoelomic. Hematogenous dissemination of breast CSCs leads to metastasis towards distant unrelated organs like lungs, liver, bone, and brain causing secondary tumor generation. Activation of metastasis genes or silencing of metastasis suppressor genes often leads to the advancement of metastasis. This review focuses on various genes and molecular factors that have been implicated to regulate organ-specific breast cancer metastasis by defying the available therapeutic interventions. 相似文献
7.
8.
9.
《Vaccine》2021,39(33):4742-4750
Allogeneic hematopoietic stem cell transplantation (alloHSCT) results in a loss of humoral immunity and subsequent risk for severe infections. Thus, re-vaccination is required but may fail due to incomplete immune reconstitution. We retrospectively analyzed predictors of immune response to primary vaccination applied according to the EBMT (European Blood and Marrow Transplantation Group) recommendations. Serologic response to vaccination against diphtheria (D), tetanus (T), Bordetella pertussis (aP) and Haemophilus influenzae (Hib) (administrated as combined DTaP-Hib-IPV vaccination) was studied in 84 alloHSCT patients transplanted between 2008 and 2015 (age at alloHSCT: 18.6–70.6 years). All patients with a relapse-free survival of ≥9 months, at least 3 consecutive vaccinations and absence of intravenous immunoglobulin administration within 3 months before and after vaccination met the primary inclusion criteria. Additionally, immunological response to a pneumococcal conjugate vaccine was analyzed in a subgroup of 67 patients. Patients’ characteristics at the time of first vaccination were recorded. Responses were measured as vaccine-specific antibody titers. Regarding DTaP-Hib-IPV vaccination, 89.3% (n = 75) of all patients achieved protective titers to at least 3 of the 4 vaccine components and were thus considered responders. 10.7% (n = 9) of the patients were classified as non-responders with positive immune response to less than 3 components. Highest response was observed for Hib (97.4%), tetanus (95.2%) and pneumococcal vaccination (83.6%) while only 68.3% responded to vaccination against Bordetella pertussis. Significant risk factors for failure of vaccination response included low B cell counts (p < 0.001; cut-off: 0.05 B cells/nl) and low IgG levels (p = 0.026; mean IgG of responders 816 mg/dl vs. 475 mg/dl of non-responders). Further, a trend was observed that prior cGvHD impairs vaccination response as 88.9% of the non-responders but only 54.7% of the responders had prior cGvHD (p = 0.073). The results demonstrate, that the currently proposed vaccination strategy leads to seroprotection in the majority of alloHSCT patients. 相似文献
10.
目的比较腹腔镜经腹腹膜前疝修补术(TAPP)与开放式腹膜前疝修补术治疗股疝的手术结果和对生活质量的影响。 方法回顾性分析2014年1月至2019年12月新疆医科大学第一附属医院收治的58例股疝患者的临床资料,根据手术方式不同分为TAPP组和开放式腹膜前疝修补术组(开放组),TAPP组31例,开放组27例。比较两组手术指标,采用卡罗来纳舒适量表(CCS)评估并比较两组患者术前及术后1、6、12和24个月的生活质量。 结果TAPP组在手术时间、术中出血量、术后住院天数及术后并发症发生率等方面和开放组相比差异无统计学意义(P>0.05);TAPP组在术后24 h疼痛视觉模拟评分及术后镇痛药使用率方面明显优于开放组(P<0.05);TAPP组术后离床时间及术后首次进食时间长于开放组(P<0.05);2组患者术后随访24个月,均无复发病例。两种术式均能有效改善患者术前的疼痛、运动受限及总体生活质量(P<0.05);TAPP组患者术后1个月疼痛及总体生活质量优于开放组(P<0.05)。 结论TAPP与开放式腹膜前疝修补术均可有效治疗股疝。TAPP可作为无全身麻醉禁忌股疝患者的首选治疗方法。股疝的治疗应依据患者的自身情况和手术医师的技术掌握程度制定个体化治疗方案。 相似文献